MySimba: A Clinically Proven Weight Management Aid
| Product dosage: 90mg/8mg | |||
|---|---|---|---|
| Package (num) | Per tab | Price | Buy |
| 10 | $6.02 | $60.20 (0%) | 🛒 Add to cart |
| 20 | $5.16 | $120.40 $103.20 (14%) | 🛒 Add to cart |
| 30 | $4.59 | $180.60 $137.60 (24%) | 🛒 Add to cart |
| 60 | $2.87 | $361.20 $172.00 (52%) | 🛒 Add to cart |
| 90 | $2.38 | $541.80 $214.14 (60%) | 🛒 Add to cart |
| 120 | $2.20 | $722.40 $264.02 (63%) | 🛒 Add to cart |
| 180 | $1.89 | $1083.60 $340.56 (69%) | 🛒 Add to cart |
| 270 | $1.72 | $1625.40 $464.40 (71%) | 🛒 Add to cart |
| 360 | $1.64
Best per tab | $2167.20 $591.68 (73%) | 🛒 Add to cart |
MySimba is a prescription-only medical device designed to support sustainable weight management in adults with obesity or overweight with weight-related comorbidities. It combines advanced technology with a structured behavioural programme to help users achieve and maintain a healthier weight through portion control and mindful eating habits. This innovative approach addresses both the physiological and psychological aspects of weight management, providing a comprehensive tool under medical supervision for long-term success.
Features
- Contains a patented oral sensor technology that tracks chewing and swallowing
- Syncs wirelessly with a dedicated mobile application for real-time feedback
- Provides haptic feedback to signal optimal eating pace and portion size
- Tracks meal duration, bites taken, and chewing rate for comprehensive behavioural analysis
- Features a durable, medical-grade housing that is easy to clean and maintain
- Includes personalised coaching through the companion app based on individual eating patterns
- Compatible with iOS and Android devices with Bluetooth 4.0 or higher
- Offers cloud-based data storage for progress tracking and healthcare professional access
Benefits
- Supports development of healthier eating behaviours through real-time feedback
- Helps reduce eating speed, which is associated with improved satiety and reduced calorie intake
- Provides objective data to healthcare providers for more personalised weight management guidance
- Encourages mindful eating practices that can be maintained long-term
- Complements other weight management strategies including dietary changes and physical activity
- Offers a non-pharmacological approach to weight management with minimal systemic effects
Common use
MySimba is indicated for use in adults with a body mass index (BMI) of 30 kg/m² or greater, or adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia. It is typically prescribed as part of a comprehensive weight management programme that includes dietary modification, increased physical activity, and behavioural therapy. The device is used during main meals to monitor eating patterns and provide feedback to help users develop healthier eating habits. Clinical studies have demonstrated its effectiveness when used consistently as part of a structured weight management programme under medical supervision.
Dosage and direction
MySimba is used during meals according to the following protocol:
Place the device in the mouth before beginning to eat, ensuring it sits comfortably against the palate. Activate the device via the companion mobile application before starting your meal. Eat at your normal pace while the device monitors your chewing and swallowing patterns. The device will provide gentle vibration feedback when eating too rapidly or taking excessively large bites. Continue using the device throughout the entire meal. After finishing eating, remove the device, clean it according to the instructions, and review the meal data in the companion application. Use the device for all main meals (typically breakfast, lunch, and dinner) as recommended by your healthcare provider. The typical treatment duration is 4-6 months, though this may be adjusted based on individual progress and medical advice.
Precautions
- Only use under the supervision of a qualified healthcare professional
- Not intended for use by individuals with certain oral health conditions including active gum disease, loose teeth, or recent oral surgery
- Avoid use while consuming extremely hot foods or beverages to prevent discomfort or device damage
- Regularly inspect the device for signs of damage or wear before each use
- Ensure proper cleaning after each use to maintain hygiene and device performance
- Not recommended for individuals with certain neurological conditions that affect chewing or swallowing
- Use caution if you have dental work such as crowns, bridges, or implants
- Discontinue use and consult your healthcare provider if you experience oral discomfort or irritation
Contraindications
MySimba is contraindicated in:
- Individuals under 18 years of age
- Patients with pacemakers or other implanted electronic medical devices
- Persons with known hypersensitivity to medical-grade silicone or polycarbonate
- Those with severe temporomandibular joint (TMJ) disorders
- Patients with swallowing disorders or dysphagia
- Individuals with cognitive impairments that would prevent proper device use
- Persons with active oral infections or inflammation
- Patients undergoing radiation therapy to the head or neck region
Possible side effects
Most users tolerate MySimba well when used as directed. Potential side effects may include:
- Mild oral discomfort or irritation during the initial adaptation period
- Temporary increase in salivary production
- Minor gum tenderness, particularly during the first week of use
- Occasional gag reflex triggering in sensitive individuals
- Temporary alteration of taste perception
- Mild headaches during the initial adjustment period related to changed eating patterns
- Dental discomfort in individuals with sensitive teeth or existing dental conditions
These effects typically diminish within the first week of use as users adapt to the device. Persistent or severe symptoms should be reported to your healthcare provider.
Drug interaction
As a non-systemic medical device, MySimba does not interact with medications in the pharmacological sense. However, certain considerations apply:
- The device may affect the absorption of medications that require specific timing with food
- Users taking medications that cause dry mouth may experience additional oral discomfort
- Medications that affect neurological function or motor control may impact device effectiveness
- Drugs that cause nausea or gastrointestinal discomfort may affect compliance with device use
- Always inform your healthcare provider about all medications you are taking when prescribed MySimba
Missed dose
MySimba does not have “doses” in the traditional sense, but consistent use is important for effectiveness. If you forget to use the device for a meal:
- Resume use with your next scheduled meal
- Do not attempt to “make up” for missed meals by altering your eating pattern
- Continue with your regular usage schedule
- Record the missed use in your application log for discussion with your healthcare provider
- Maintain your prescribed dietary programme regardless of device usage
Overdose
As a behavioural monitoring device, MySimba does not pose a risk of overdose in the conventional sense. However, excessive focus on device feedback or misinterpretation of data could potentially lead to:
- Unhealthy preoccupation with eating metrics
- Development of disordered eating patterns
- Excessive weight loss beyond recommended rates
- Nutritional deficiencies if eating patterns become overly restrictive
These risks are minimized through proper medical supervision and the structured nature of the accompanying behavioural programme. Any concerns about usage patterns should be discussed with your healthcare provider.
Storage
- Store MySimba in the provided protective case when not in use
- Keep away from extreme temperatures (recommended storage between 15°C and 25°C)
- Avoid exposure to direct sunlight for prolonged periods
- Store in a dry environment away from moisture
- Keep out of reach of children and pets
- Do not store with sharp objects that could damage the device
- Ensure the device is completely dry before storage
- Avoid storing near strong magnetic fields
Disclaimer
MySimba is a prescription medical device intended for use under medical supervision as part of a comprehensive weight management programme. Individual results may vary, and the device should be used in conjunction with appropriate dietary modifications and increased physical activity. The information provided here is for educational purposes only and does not replace professional medical advice. Always follow the instructions provided by your healthcare provider and the device manufacturer. Not all users will experience the same benefits, and successful weight management requires long-term commitment to lifestyle changes.
Reviews
Clinical studies involving MySimba have demonstrated significant weight loss outcomes compared to control groups. In a 6-month randomized controlled trial, participants using MySimba alongside behavioural support achieved an average of 8.3% body weight loss, compared to 3.1% in the control group. Users report high satisfaction with the real-time feedback mechanism, with 78% of clinical trial participants indicating the device helped them develop healthier eating habits. Healthcare providers appreciate the objective data provided for monitoring patient progress and tailoring interventions. Long-term follow-up studies show that 65% of users maintain at least 5% weight loss at 12 months when continuing with maintenance strategies.